Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$5.88 USD
-0.61 (-9.34%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $5.87 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-1.20 | 0.00% |
Earnings Summary
For their last quarter, Inovio Pharmaceuticals (INO) reported earnings of -$1.19 per share, missing the Zacks Consensus Estimate of -$1.15 per share. This reflects a negative earnings surprise of 3.48%. Look out for INO's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$1.20 per share, reflecting a year-over-year decrease of 11.11%.
Earnings History
Price & Consensus
Zacks News for INO
Castle Biosciences, Inc. (CSTL) Q2 Earnings and Revenues Beat Estimates
INO: What are Zacks experts saying now?
Zacks Private Portfolio Services